Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranolazine in Pulmonary Hypertension Associated With Diastolic Left Ventricular Dysfunction
NCT02133352Phase 4Completed
- Sponsor
- Boston University
- Start
- Jul 2011
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ranolazine in pulmonary hypertension (PH), sponsored by Boston University. Started Jul 2011; status: completed.
02
Drugs
ranolazine
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT02133352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02133352.